Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-24-064598

Chief Financial Officer sold 4,350 shares at $2.64 ($11,485)

  • Chief Financial Officer acquired 16,043 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Delfini Lisa · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-22 Exercise or conversion : show line 1 in the form +16,043 $0.51 $8,198 57,629 D
2024-05-22 Sale : show line 2 in the form −4,350 $2.64 $11,485 53,279 D
Open-market sales · 4,350 sh · avg $2.64 · $11,485

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-22 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −16,043 48,125 D
Loading xslF345X05/ownership.xml…